Literature DB >> 9580883

Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins.

M da Silva Cardoso1, K Siemoneit, D Sturm, C Krone, D Moradpour, B Kubanek.   

Abstract

The isolation and characterization of human monoclonal antibodies (humAbs) against the hepatitis C Virus (HCV) glycoproteins E1 and E2 are described. B-cells from blood donors with anti-HCV were transformed with Epstein-Barr virus. The supernatants of the resulting lymphoblastoid clones were screened by ELISA with an extract of cells infected with a recombinant vaccinia virus RMPA95 expressing the envelope proteins E1 and E2 of an HCV genotype 1a virus (H strain). Positive clones were fused to the heteromyeloma cell line K6H6/B5. Fifteen heterohybridoma cell lines have been established. The specificity of the isolated humAbs was determined both by ELISA and Western blot assays. Several recombinant extracts expressing either the E1 or E2 protein or truncated forms were used in an attempt to map the epitopes on the viral glycoproteins. Some of the humAbs were used successfully for immunofluorescence investigation of transfected cells. Seven specific anti-E2 humAbs, which react with the envelope protein 2 of genotype 1a and 1b isolates, were characterized.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9580883

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  9 in total

1.  Preclinical evaluation of two neutralizing human monoclonal antibodies against hepatitis C virus (HCV): a potential treatment to prevent HCV reinfection in liver transplant patients.

Authors:  Rachel Eren; Dorit Landstein; Dov Terkieltaub; Ofer Nussbaum; Arie Zauberman; Judith Ben-Porath; Judith Gopher; Rachel Buchnick; Riva Kovjazin; Ziva Rosenthal-Galili; Sigal Aviel; Ehud Ilan; Yariv Shoshany; Lewis Neville; Tal Waisman; Ofer Ben-Moshe; Alberto Kischitsky; Steven K H Foung; Zhen-Yong Keck; Orit Pappo; Ahmed Eid; Oded Jurim; Gidi Zamir; Eithan Galun; Shlomo Dagan
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

Review 2.  Use of Human Hybridoma Technology To Isolate Human Monoclonal Antibodies.

Authors:  Scott A Smith; James E Crowe
Journal:  Microbiol Spectr       Date:  2015-02

3.  Expression and immunoreactivity of HCV/HBV epitopes.

Authors:  Xin-Yu Xiong; Xiao Liu; Yuan-Ding Chen
Journal:  World J Gastroenterol       Date:  2005-11-07       Impact factor: 5.742

4.  Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes.

Authors:  K G Hadlock; R E Lanford; S Perkins; J Rowe; Q Yang; S Levy; P Pileri; S Abrignani; S K Foung
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines.

Authors:  Sabine Wellnitz; Bettina Klumpp; Heidi Barth; Susumu Ito; Erik Depla; Jean Dubuisson; Hubert E Blum; Thomas F Baumert
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  CD81-dependent binding of hepatitis C virus E1E2 heterodimers.

Authors:  Laurence Cocquerel; Chiung-Chi Kuo; Jean Dubuisson; Shoshana Levy
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions.

Authors:  Zhen-Yong Keck; Anne Op De Beeck; Kenneth G Hadlock; Jinming Xia; Ta-Kai Li; Jean Dubuisson; Steven K H Foung
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Recognition of native hepatitis C virus E1E2 heterodimers by a human monoclonal antibody.

Authors:  Laurence Cocquerel; Elizabeth R Quinn; Mike Flint; Kenneth G Hadlock; Steven K H Foung; Shoshana Levy
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

9.  Evaluation of the fusion partner cell line SPYMEG for obtaining human monoclonal antibodies against influenza B virus.

Authors:  Priyanka Soni; Atsuhiro Yasuhara; Toru Takenaga; Kiyoko Iwatsuki-Horimoto; Ryuta Uraki; Mutsumi Ito; Tadahiro Sasaki; Kazuyoshi Ikuta; Seiya Yamayoshi; Yoshihiro Kawaoka
Journal:  J Vet Med Sci       Date:  2018-04-17       Impact factor: 1.267

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.